BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou H, Xu Z, Liao X, Tang S, Li N, Hou S. Low Expression of YTH Domain-Containing 1 Promotes Microglial M1 Polarization by Reducing the Stability of Sirtuin 1 mRNA. Front Cell Neurosci 2021;15:774305. [PMID: 34975410 DOI: 10.3389/fncel.2021.774305] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen J, Xiao L, Chen Y, Li W, Liu Y, Zhou Y, Tan H. YT521-B homology domain containing 1 ameliorates mitochondrial damage and ferroptosis in sleep deprivation by activating the sirtuin 1/nuclear factor erythroid-derived 2-like 2/heme oxygenase 1 pathway. Brain Res Bull 2023:S0361-9230(23)00061-8. [PMID: 36935054 DOI: 10.1016/j.brainresbull.2023.03.008] [Reference Citation Analysis]
2 Ni Y, Zhang H, Chu L, Zhao Y. m6A Modification-Association with Oxidative Stress and Implications on Eye Diseases. Antioxidants (Basel) 2023;12. [PMID: 36830067 DOI: 10.3390/antiox12020510] [Reference Citation Analysis]
3 Fan Y, Lv X, Chen Z, Peng Y, Zhang M. m6A methylation: Critical roles in aging and neurological diseases. Front Mol Neurosci 2023;16:1102147. [PMID: 36896007 DOI: 10.3389/fnmol.2023.1102147] [Reference Citation Analysis]
4 Zhang K, Li P, Jia Y, Liu M, Jiang J. Non-coding RNA and n6-methyladenosine modification play crucial roles in neuropathic pain. Front Mol Neurosci 2022;15. [DOI: 10.3389/fnmol.2022.1002018] [Reference Citation Analysis]
5 He S, Li W, Wang G, Wang X, Fan W, Zhang Z, Li N, Hou S. FTO-mediated m6A modification alleviates autoimmune uveitis by regulating microglia phenotypes via the GPC4/TLR4/NF-κB signaling axis. Genes & Diseases 2022. [DOI: 10.1016/j.gendis.2022.09.008] [Reference Citation Analysis]
6 Liu D, Fan B, Li J, Sun T, Ma J, Zhou X, Feng S. N6-methyladenosine modification: A potential regulatory mechanism in spinal cord injury. Front Cell Neurosci 2022;16:989637. [DOI: 10.3389/fncel.2022.989637] [Reference Citation Analysis]
7 Maimaiti A, Turhon M, Cheng X, Su R, Kadeer K, Axier A, Ailaiti D, Aili Y, Abudusalamu R, Kuerban A, Wang Z, Aisha M. m6A regulator–mediated RNA methylation modification patterns and immune microenvironment infiltration characterization in patients with intracranial aneurysms. Front Neurol 2022;13:889141. [DOI: 10.3389/fneur.2022.889141] [Reference Citation Analysis]
8 Tang S, Meng J, Tan J, Liu X, Zhou H, Li N, Hou S. N6-methyladenosine demethylase FTO regulates inflammatory cytokine secretion and tight junctions in retinal pigment epithelium cells. Clin Immunol 2022;241:109080. [PMID: 35878734 DOI: 10.1016/j.clim.2022.109080] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Meng J, Liu X, Tang S, Liu Y, Zhao C, Zhou Q, Li N, Hou S. METTL3 inhibits inflammation of retinal pigment epithelium cells by regulating NR2F1 in an m6A-dependent manner. Front Immunol 2022;13:905211. [DOI: 10.3389/fimmu.2022.905211] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Ding L, Wu H, Wang Y, Li Y, Liang Z, Xia X, Zheng JC. m6A Reader Igf2bp1 Regulates the Inflammatory Responses of Microglia by Stabilizing Gbp11 and Cp mRNAs. Front Immunol 2022;13:872252. [DOI: 10.3389/fimmu.2022.872252] [Reference Citation Analysis]